Vectura Group Share Price (VEC)

137.95 -2.05 (-1.46%) delayed: 9:03PM BST
Bid price 137.80 Open price 140.70
Ask price 138.10 Prev close 138.00
High price 140.70 Spread 0.22%
Low price 135.00 Volume 1,092,795

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 137.95 Net Gearing (%) -17.92
Market Capitalisation (£m) 574.74 Gross Gearing (%) 17.01
Shares in issue (m) 410.53 Debt Ratio 8.28
P/E Ratio 116.67 Debt-to-Equity Ratio 0.44
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 2.42
Dividend cover (x) 0.00 ROCE (%) -0.73
Earning per share (p) 1.20 EPS Growth (%) 33.33
52 week high / low 200.00 / 138.45 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
08/07/2016 EXR Andrew Derodra FD 344,267
08/07/2016 SEXR Andrew Derodra FD 263,364
20/06/2016 EXR Andrew Derodra FD 150,000
20/06/2016 SEXR Andrew Derodra FD 150,000
14/06/2016 EXR Andrew Derodra FD 279,774

More Vectura Group Director Deals >>

Vectura Group Company News

07:26 05/08/2016

Vectura triggers $8m milestone for Exparel

Vectura Group said a sales milestone receipt of $8m has been triggered following confirmation by Pacira Pharmaceuticals that worldwide annual net sales of Exparel to June 30 were above $250m. On Aug. 4, Pacira announced net sales of Exparel of $65.8m in Q2 2016, an increase of 15% compared with...

07:10 05/08/2016

FLASH: Vectura triggers $8m milestone for Exparel

Story provided by

07:03 05/08/2016

US$8 million Exparel® sales milestone from Pacira

/* */ RNS Number : 3617G Vectura Group plc 05 August 2016   Vectura Group plc US$8 million Exparel ® sales milestone from Pacira triggered This announcement includes inside information   Chippenham, UK - 5 August 2016:  Vectura Group...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago


Powered by IST's

Register now for FREE Vectura Group share price discussions